MindRank AI
Research - Shanghai, Shanghai, China
MindRank AI Details
MindRank (www.mindrank.ai) is an AI-driven biotech company with focus on "Undruggable" targets. The company started operations in 2021 and now consists of 35 scientists with R&D center in China and UK. The company is led by academicians of the British Royal Society, former R&D scientists from top pharma companies and the global AI competition winners. The team has successful experience in drug R&D and have a large number top publications including Nature Biomedical Engineering, Nature Machine Intelligence, Patterns (Cell Press) etc.By leveraging its proprietary AI driven drug discovery platform, MindRank has delivered a small molecule Preclinical Candidate (allosteric inhibitor) to a listed biotechnology company in Sept 2021. In Jan 2022, MindRank begins IND-enabling studies of its proprietary AI-designed drug (Class B GPCR), 8 months after program initiation. Both of the small molecule drugs are expected to enter clinical phase in 2022.
MindRank AI Technologies
Email Providers
Gmail
Other
Mobile Friendly
Hosting
Amazon AWS
CSS and JavaScript Libraries
React Redux